BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR Phase I grant (R43AG094410) from the National Institutes of Health (NIH) to ...

Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular ...

State-of-the-art technology could accelerate novel drug development, advance precision medicine Intellicule founders Purdue ...

Oligomerix Awarded $0.5 M phase I NIH SBIR Fast-Track Grant to Conduct Safety Studies that will Support Clinical Studies of OLX-07010 for Alzheimer’s Patients -- Company gains NIH Fast-Track award ...

What is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will ...

NIH funding supports a clinical trial of Storii’s telephone-based memoir service that reduces isolation, improves mental health, and connects rural older adults With just a telephone call, we’re ...

Oligomerix, Inc., a privately held clinical stage company pioneering the development of oral, small molecule therapeutics targeting Alzheimer’s (AD) and rare neurodegenerative diseases, announced an ...

Business Consumer Alliance reports that joining a business membership organization offers networking, training, resources, ...